U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H14N2
Molecular Weight 162.2316
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-PHENYLPIPERAZINE

SMILES

C1CN(CCN1)C2=CC=CC=C2

InChI

InChIKey=YZTJYBJCZXZGCT-UHFFFAOYSA-N
InChI=1S/C10H14N2/c1-2-4-10(5-3-1)12-8-6-11-7-9-12/h1-5,11H,6-9H2

HIDE SMILES / InChI

Molecular Formula C10H14N2
Molecular Weight 162.2316
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Oxidation of fluoroquinolone antibiotics and structurally related amines by chlorine dioxide: Reaction kinetics, product and pathway evaluation.
2010-12
Search for influence of spatial properties on affinity at α1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.
2010-10-15
Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry.
2010-10-01
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.
2010-09-15
[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.
2010-06
Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581.
2010-05-01
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).
2010-03-25
Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.
2010-03-01
Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways.
2010-03
Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: a new step towards the design of high-affinity 5-HT1A ligands.
2010-02-01
Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
2010-01-07
Animal violence demystified.
2010
[(18)F]-labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent.
2009-11
Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3.
2009-09-15
[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.
2009-09
Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
2009-08-13
Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.
2009-07-01
Acaricidal properties of piperazine and its derivatives against house-dust and stored-food mites.
2009-06
Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
2009-05-28
Application of a library of artificial receptors formed by the self-organization of N-lipidated peptides immobilized on cellulose in studying the effects of the incorporation of a fluorine atom.
2009-04-17
SONU20176289, a compound combining partial dopamine D(2) receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression.
2008-11-19
Probe compounds to quantify cation exchange and complexation interactions of ciprofloxacin with soils.
2008-11-15
Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.
2008-11-05
Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.
2008-09-01
FT-IR spectroscopic investigation of some Hofmann type complexes: M(1-phenylpiperazine)2Ni(CN)4 (M=Ni, Co, Cd, Pd or Mn).
2008-07
Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
2008-06-01
Pharmacokinetic evaluation of LASSBio-579: an N-phenylpiperazine antipsychotic prototype.
2008-06
(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.
2008-04-24
Determination of lipophilicity of alpha-(4-phenylpiperazine) derivatives of N-benzylamides using chromatographic and computational methods.
2008-04
Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581.
2008-03
Patented small molecule inhibitors in the ubiquitin proteasome system.
2007-11-22
Two new phenylpiperazines with atypical antipsychotic potential.
2007-11-01
From tyrosine to glycine: synthesis and biological activity of potent antagonists of the purinergic P2X7 receptor.
2007-07-26
FT-IR and NMR investigation of 1-phenylpiperazine: a combined experimental and theoretical study.
2007-07
Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
2007-04
Identification of metabolites produced from N-phenylpiperazine by Mycobacterium spp.
2007-03
Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
2007-02-24
Trazodone for Alzheimer's disease: a naturalistic follow-up study.
2007-02-07
Adsorption and oxidation of fluoroquinolone antibacterial agents and structurally related amines with goethite.
2007-01
Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
2006-11-15
Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors.
2006-08-24
BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline.
2006-04-01
Binding and photocleavage of cationic porphyrin-phenylpiperazine hybrids to DNA.
2006-02-01
In vitro metabolism studies of (18)F-labeled 1-phenylpiperazine using mouse liver S9 fraction.
2006-02
Synthesis of potent and selective serotonin 5-HT1B receptor ligands.
2005-11-01
Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.
2005-11-01
Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.
2005-10-10
Pharmacokinetics and tissue distribution of a new heterocyclic N-phenylpiperazine derivative (LASSBio-581) in rats.
2005-10
[A study of physicochemical properties of 2-, 3-, 4-alkoxyphenylcarbamic acid derivatives with a substituted N-phenylpiperazine moiety in the basic part].
2005-09
Fluorous reagents and scavengers versus solid-supported reagents and scavengers, a reaction rate and kinetic comparison.
2005
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:23:35 GMT 2025
Edited
by admin
on Mon Mar 31 19:23:35 GMT 2025
Record UNII
J9225CBI7D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1-PHENYLPIPERAZINE
Systematic Name English
N-PHENYLDIETHYLENEDIAMINE
Preferred Name English
PHENYLPIPERAZINE, 1-
Systematic Name English
LEVODROPROPIZINE IMPURITY B [EP IMPURITY]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID8057855
Created by admin on Mon Mar 31 19:23:35 GMT 2025 , Edited by admin on Mon Mar 31 19:23:35 GMT 2025
PRIMARY
MESH
C031503
Created by admin on Mon Mar 31 19:23:35 GMT 2025 , Edited by admin on Mon Mar 31 19:23:35 GMT 2025
PRIMARY
PUBCHEM
7096
Created by admin on Mon Mar 31 19:23:35 GMT 2025 , Edited by admin on Mon Mar 31 19:23:35 GMT 2025
PRIMARY
WIKIPEDIA
Phenylpiperazine
Created by admin on Mon Mar 31 19:23:35 GMT 2025 , Edited by admin on Mon Mar 31 19:23:35 GMT 2025
PRIMARY
ECHA (EC/EINECS)
202-165-6
Created by admin on Mon Mar 31 19:23:35 GMT 2025 , Edited by admin on Mon Mar 31 19:23:35 GMT 2025
PRIMARY
FDA UNII
J9225CBI7D
Created by admin on Mon Mar 31 19:23:35 GMT 2025 , Edited by admin on Mon Mar 31 19:23:35 GMT 2025
PRIMARY
CAS
92-54-6
Created by admin on Mon Mar 31 19:23:35 GMT 2025 , Edited by admin on Mon Mar 31 19:23:35 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP